Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine
Open Access
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (5) , 1071-1076
- https://doi.org/10.1016/0006-2952(90)90495-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- INHIBITION OF ACETYLCHOLINESTERASE BY VARIOUS OPIOIDSClinical and Experimental Pharmacology and Physiology, 1986
- Procaine as a substrate and possible allosteric effector of cholinesterasesNeurochemistry International, 1983
- An Amphiphile‐Dependent Form of Human Brain Caudate Nucleus Acetylcholinesterase: Purification and PropertiesJournal of Neurochemistry, 1982
- Alzheimer's Disease: X-Ray Spectrometric Evidence of Aluminum Accumulation in Neurofibrillary Tangle-Bearing NeuronsScience, 1980
- Hydrophobic binding site in acetylcholinesteraseJournal of Medicinal Chemistry, 1975
- Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium bindingBiochemistry, 1975
- Ligand binding properties of acetylcholinesterase determined with fluorescent probesBiochemistry, 1974
- Inhibition of Cholinesterases by Tetrahydroaminacrin.Acta Chemica Scandinavica, 1961
- The inhibitory effect of stilbamidine, curare and related compounds and its relationship to the active groups of acetylcholine esterase. Action of stilbamidine upon nerve impulse conductionBiochimica et Biophysica Acta, 1950